196 related articles for article (PubMed ID: 17261581)
1. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
Wright CW; Rumble JM; Duckett CS
J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
[TBL] [Abstract][Full Text] [Related]
2. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
Buchan SL; Al-Shamkhani A
PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
Nishikori M; Ohno H; Haga H; Uchiyama T
Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
[TBL] [Abstract][Full Text] [Related]
4. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
5. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
Mir SS; Richter BW; Duckett CS
Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
[TBL] [Abstract][Full Text] [Related]
7. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
8. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
Ok CY; Xu-Monette ZY; Li L; Manyam GC; Montes-Moreno S; Tzankov A; Visco C; Dybkær K; Routbort MJ; Zhang L; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Rao H; Møller MB; Winter JN; Piris MA; Wang SA; Medeiros LJ; Young KH
Mod Pathol; 2015 Sep; 28(9):1202-13. PubMed ID: 26111978
[TBL] [Abstract][Full Text] [Related]
10. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
[TBL] [Abstract][Full Text] [Related]
11. Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.
Zheng B; Georgakis GV; Li Y; Bharti A; McConkey D; Aggarwal BB; Younes A
Clin Cancer Res; 2004 May; 10(9):3207-15. PubMed ID: 15131062
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells.
Suzuki O; Hirsch B; Abe M; Dürkop H; Stein H
Lab Invest; 2012 Feb; 92(2):191-9. PubMed ID: 21986812
[TBL] [Abstract][Full Text] [Related]
13. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription.
Wright CW; Duckett CS
Science; 2009 Jan; 323(5911):251-5. PubMed ID: 19131627
[TBL] [Abstract][Full Text] [Related]
15. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
Toda T; Watanabe M; Kawato J; Kadin ME; Higashihara M; Kunisada T; Umezawa K; Horie R
Br J Haematol; 2015 Sep; 170(6):837-46. PubMed ID: 26105086
[TBL] [Abstract][Full Text] [Related]
16. Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines.
Watanabe M; Nakano K; Togano T; Nakashima M; Higashihara M; Kadin ME; Watanabe T; Horie R
Oncol Res; 2011; 19(10-11):463-9. PubMed ID: 22715589
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction in anaplastic large cell lymphoma cells (ALCL) mediated by the tumor necrosis factor receptor CD30.
Schneider C; Stöhr D; Merz H; Hübinger G
Leuk Lymphoma; 2004 May; 45(5):1009-15. PubMed ID: 15291361
[TBL] [Abstract][Full Text] [Related]
18. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.
Gamboa-Cedeño AM; Castillo M; Xiao W; Waldmann TA; Ranuncolo SM
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1437-1448. PubMed ID: 30941572
[TBL] [Abstract][Full Text] [Related]
19. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]